Warren Buffett, the CEO and Chairman of Berkshire Hathaway (BRK.A)/(BRK.B), announced on Thursday to borrow $8 billion of loan for the acquisition of Burlington Northern Santa Fe Corporation (BNI). Berkshire Hathaway, which already owns a 22% stake in Burlington Northern, announced earlier this month it would acquire the rest for a total value of $34 billion. Buffet agreed to pay $100 a share in cash and stock to buy the rest of the company. The $8 billion loan that will be provided by JPMorgan Chase (JPM) and Wells Fargo (WFC) is intended to be paid back in three years’ time. For Berkshire, the acquisition of Burlington Northern, or BNSF, the second largest railroad, will be its biggest to date. With it, Berkshire is adding a railroad transportation business with its already diverse range of businesses including retail, manufacturing and insurance, as well ...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Tuesday November 10, 2009

DrStockPick.com Stock Report!

**************************************************************

Power3 Medical Products, Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and cancer biomarkers and diagnostic tests, announces further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf, will deliver an invited Keynote address and chair a session on “Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is “New Leadership of

...

MMR Information Systems today described to investors the benefits of its MMRPro system for Electronic Medical Records (EMR). This system will utilize a proprietary, Kodak-branded architecture and will enable any medical practice, even small or mid-sized, to achieve standards in medical record computerization that qualifies them for funding under the American Recovery and Reinvestment Act (ARRA).

The entire MMRPro system should come in at under $20,000 over three years, a price point that trounces all competitors, as a typical EMR solution requires many times that much for only a single year. CEO and Chairman of MMRF, Robert H. Lorsch, quieted concerns raised last week in an article by the Washington Post that cited gross inconsistencies and inaccurate medications resulting from EMR systems by detailing the universality of the approach enabled by his Company’s MMRPro system.

Lorsch boldly proclaimed his Company’s commitment to resolving this situation through its software, saying that mistakes

...

• Eli Lilly (NYSE:LLY) reported third quarter earnings of $1.20 a share, 18 cents ahead of Zacks estimates, on third quarter revenues of $5.56 billion.  The company said, "Our performance in the third quarter once again was driven by volume-based sales growth, improving gross margins and tight control of operating expenses, allowing us to deliver very attractive earnings growth"

• Yahoo (NASDAQ:YHOO) results beat Zacks estimates of 7 cents, coming in at 13 cents, as the company’s operations benefitted from cost-cutting measures; revenues held steady with last quarter's at $1.13 billion.  According to CFO Morse, "There's a change occurring in Yahoo, that will value that kind of work - that good old-fashioned, get-your-hands-dirty kind of find ways to take costs down or make sure that they don't go up as much as they otherwise would have - type work"

• SanDisk (NASDAQ:SNDK) results also beat projections on earnings of 75 cents, well

...

  We are initiating coverage of DARA BioSciences (DARA) with an Outperform rating and price target of $1.60 per share. We believe that DARA is poised to deliver meaningful news flow on the pipeline over the next several quarters -- something the company has been lacking over the past year due to funding constraints. DARA has been slowly rebuilding its business over the past two years following the failure and discontinuation of phase III advanced non-small cell lung cancer drug talabostat in mid-2007. Headcount is down to only 5 employees, and the company has spent the last year rebuilding the Board and refocusing the pipeline. Meanwhile, the stock languished in 2008 with little to no clinical news flow. Richard Franco rejoined the company as CEO and Chairman in January 2009. He had two key objectives for 2009: secure funding for future operations and advance the pipeline forward. Over ...

Headquartered in Shanghai, China Energy is an international leader in designing, fabricating, implementing and servicing energy recovery systems. With state-of-the-art technology which captures industrial waste energy to produce low cost electrical power, the company enables industrial manufacturers to reduce their energy costs, shrink their emissions footprint, and generate sellable emissions credits. With a growing reputation, China Energy caught the attention of investors globally with the announcement that it has completed a major contract for the Hubei Yangfeng Group which has a total value of $1.42 million.

This completed project will not only represent growth in the economy but will also help the environment. For example, while the $1.42 million will help China Energy Recovery embrace a new financial spectrum, the completed systems are designed to generate 120 tons of steam per hour, which translates into nearly 24MW of thermo power generation capacity. These systems will help Yangfeng achieve

...

Formerly known as Ophthalmic Technologies Inc. Opko Health has recently agreed to acquire Chilean pharmaceutical company named Pharma Genexx for around US$ 16 million in cash. One of the reasons why this Florida-based pharma giant is taking up Chilean pharmaceutical is to enter the emerging markets in the future. The Miami-based Opko Health is a specialty healthcare company that is currently involved in the discovery, development and commercialization of pharmaceutical products, vaccines and diagnostic technologies. However, with this acquisition Opko Health is looking to expand into new areas like oncology and neurological disorders.

Opko Health CEO and Chairman Philip Frost have said that Opko Health believes that this acquisition will be an excellent strategic fit for Opko to expand further into international market. Currently, Pharma Genexx is involved in the representation,

...

Gap Inc. (GPS) reported comparable store sales slipping by 3% year-over-year. While sales were slightly lower, which is not unique amid the current economic environment, GPS shares continued climbing and are trading close to a 52-high. The company also recently released sad news, announcing that Donald G. Fisher, co-founder of Gap, died after a long and heroic battle with cancer.

Company Description

Gap Inc. is a global specialty retailer that sells clothing, accessories and personal care products for men, women, children and babies under the Gap, Old Navy, Banana Republic, Piperlime and Athleta brands. The company operates stores in the United States, Canada, the United Kingdom, France, Ireland and Japan.

Gap also has franchise agreements with unaffiliated franchisees to operate Gap and Banana Republic stores in many other countries around the world. Under these agreements, third parties operate or will operate stores that sell apparel, purchased from Gap, under Gap's brand

...

China Armco Metals, Inc., a distributor of imported metal ore with plans to build a new state of the art scrap metal recycling facility in China, announced today that Armco Metawise, Ltd., the company’s wholly owned subsidiary, has delivered the last of iron ore to a China based steel company pursuant to a contract that is expected to generate revenues of approximately $8 million in the third quarter of 2009.

Commenting on the contract, Mr. Kexuan Yao, CEO and Chairman of China Armco Metals, Inc., stated, “We are extremely pleased with the strong sales efforts we have made in the third quarter. We worked diligently with this new customer to deliver this order and hope to secure additional orders in the future. Expanding our customer base is critical as we build for future growth and we expect our sales efforts will continue to gain momentum in the coming months.”

Let us hear

...

American Lorain Corp., an international processed foods company based in Shandong Province, People’s Republic of China, announced that it has received authorization to list its common stock on the NYSE Amex Exchange and will begin trading on Tuesday, September 8, 2009 under the ticker symbol “ALN.”

“Moving from the OTC BB to NYSE Amex is a major milestone for American Lorain, as we strive to improve liquidity and transparency for our shareholders. Trading on NYSE Amex is also an important endorsement of the Company as a major player in the food processing industry in China and helps us build credibility with our customers worldwide,” stated Mr. Si Chen, CEO and Chairman of American Lorain.

He continued, “We are excited and honored to join the NYSE Amex group of companies and expect to attract additional interest from the investment community following our listing on this senior exchange. We wish to thank

...